BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 35684498)

  • 1. Involvement of Phytochemical-Encapsulated Nanoparticles' Interaction with Cellular Signalling in the Amelioration of Benign and Malignant Brain Tumours.
    Mehan S; Arora N; Bhalla S; Khan A; U Rehman M; Alghamdi BS; Zughaibi TA; Ashraf GM
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Glioblastoma Multiforme by Phytochemicals: Applications of Nanoparticle-Based Targeted Drug Delivery System.
    Mumtaz SM; Bhardwaj G; Goswami S; Tonk RK; Goyal RK; Abu-Izneid T; Pottoo FH
    Curr Drug Targets; 2021; 22(4):429-442. PubMed ID: 32718288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
    Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
    Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of High-Grade Astrocytomas in Adults.
    Puduvalli VK; Hoang N
    Prog Neurol Surg; 2018; 31():116-144. PubMed ID: 29393181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neoplastic Potential of Flavonoids and Polysaccharide Phytochemicals in Glioblastoma.
    Atiq A; Parhar I
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intraarterial route of drug delivery in the chemotherapy of malignant brain tumours.
    Loew F; Papavero L
    Adv Tech Stand Neurosurg; 1988; 16():51-79. PubMed ID: 3064756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular mechanisms of glioblastoma malignancy: Implications in resistance and therapeutic strategies.
    Balça-Silva J; Matias D; Carmo AD; Sarmento-Ribeiro AB; Lopes MC; Moura-Neto V
    Semin Cancer Biol; 2019 Oct; 58():130-141. PubMed ID: 30266571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview.
    Guidotti G; Brambilla L; Rossi D
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted brain delivery nanoparticles for malignant gliomas.
    Pinto MP; Arce M; Yameen B; Vilos C
    Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology-based cancer chemoprevention in glioblastoma.
    Adylova A; Kapanova G; Datkhayeva Z; Raganina K; Tanbayeva G; Baigonova K
    Folia Neuropathol; 2023; 61(3):235-241. PubMed ID: 37818684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Progress of Phytomedicine in Glioblastoma Therapy.
    Shah FH; Salman S; Idrees J; Idrees F; Shah STA; Khan AA; Ahmad B
    Curr Med Sci; 2020 Dec; 40(6):1067-1074. PubMed ID: 33428134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined cytostatic treatment of malignant brain tumors (author's transl)].
    Heiss WD; Kroiss A; Kühböck J; Profanter W
    MMW Munch Med Wochenschr; 1974 Nov; 116(45):1957-60. PubMed ID: 4374657
    [No Abstract]   [Full Text] [Related]  

  • 17. New frontiers for astrocytic tumours.
    Nano R; Lascialfari A; Corti M; Paolini A; Pasi F; Corbella F; DI Liberto R
    Anticancer Res; 2012 Jul; 32(7):2755-8. PubMed ID: 22753735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing incidence and improved survival of gliomas.
    Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
    Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.
    Pistollato F; Bremer-Hoffmann S; Basso G; Cano SS; Elio I; Vergara MM; Giampieri F; Battino M
    Target Oncol; 2016 Feb; 11(1):1-16. PubMed ID: 26275397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.